Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Tawazun Council, RTX and EGA Sign MOU to Explore Gallium Production in Abu Dhabi

ABU DHABI, May 16, 2025 /PRNewswire/ -- Today, Tawazun Council; aerospace and defense company RTX (NYSE: RTX); and Emirates Global Aluminium (EGA), the world's largest producer of "premium aluminium," signed a memorandum of understanding to establish EGA as a new producer of gallium, a …

EODHD | 16 May 2025

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® (berotralstat) in adolescents and people with severe HAE showing significant and sustained reductions in …

EODHD | 16 May 2025

Brady Corporation Reports Record Adjusted EPS in its Fiscal 2025 Third Quarter and Tightens its Fiscal 2025 EPS Guidance

Brady Corporation Sales for the quarter increased 11.4 percent. Organic sales increased 1.6 percent, acquisitions increased sales 10.5 percent and foreign currency translation decreased sales 0.7 percent. Diluted EPS increased 3.8 percent to $1.09 in the third quarter of fiscal 2025 compared to $1.05 …

EODHD | 16 May 2025

AngloGold Ashanti's (NYSE:AU) Earnings Are Weaker Than They Seem

AngloGold Ashanti plc (NYSE:AU) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders have noticed something concerning in the numbers. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the …

EODHD | 16 May 2025

Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%

Approval based on results from the CheckMate-77T trial which showed perioperative Opdivo improved event-free survival compared to neoadjuvant chemotherapy and placebo followed by surgery and adjuvant placebo Opdivo is now the only PD-(L)1 inhibitor approved for both perioperative and neoadjuvant-only treatment of resectable non-small …

EODHD | 16 May 2025

Cameco Corporation (CCJ) Fell Following President Trump’s 10% Tariff on Canadian Energy Exports

Aristotle Capital Management, LLC, an investment management company, released its “Global Equity Strategy” first quarter 2025 investor letter. A copy of the same can be downloaded here. Global equity markets experienced a negative Q1 return, while global fixed income grew. Value stocks outpaced growth, …

EODHD | 16 May 2025

What Makes REV Group (REVG) a Good Investment?

Aberdeen Investments, an investment management company, released its “abrdn U.S. Small Cap Equity Fund” Q1 2025 investor letter. A copy of the letter can be downloaded here. US small caps experienced a significant drop in Q1 and a lower return than the broader US …

EODHD | 16 May 2025

Boot Barn Holdings Full Year 2025 Earnings: In Line With Expectations

Boot Barn Holdings (NYSE:BOOT) Full Year 2025 Results Key Financial Results Revenue: US$1.91b (up 15% from FY 2024). Net income: US$180.9m (up 23% from FY 2024). Profit margin: 9.5% (in line with FY 2024). EPS: US$5.93 (up from US$4.87 in FY 2024). Trump has …

EODHD | 16 May 2025

Cellebrite DI First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Cellebrite DI (NASDAQ:CLBT) First Quarter 2025 Results Key Financial Results Revenue: US$107.5m (up 20% from 1Q 2024). Net income: US$17.4m (up from US$71.4m loss in 1Q 2024). Profit margin: 16% (up from net loss in 1Q 2024). The move to profitability was primarily driven …

EODHD | 16 May 2025

Procter & Gamble Stock Slips 5% in a Month: Buy the Dip or Stay Wary?

The Procter & Gamble Company PG, also known as P&G, has displayed a slowdown in the share price performance in the past month, with its stock falling as much as 4.8%. The PG stock’s dismal performance on the bourses is attributed to the company’s …

EODHD | 16 May 2025